EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor.
about
Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.An imaging agent to detect androgen receptor and its active splice variants in prostate cancerSintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.Non-Genomic Actions of the Androgen Receptor in Prostate CancerAn Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation.Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.Regulation of Androgen Receptor Activity by Transient Interactions of Its Transactivation Domain with General Transcription Regulators.Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.[Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer].Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.Androgen deprivation and immunotherapy for the treatment of prostate cancer
P2860
Q36237251-5A33954E-DE5A-42C8-8647-4651FEF375A8Q37165574-8FB6100C-1F52-4247-A43F-FCA19781EA4BQ37338900-27756444-76BD-44AD-BB84-7D4BD3FE4328Q37496652-0508C82C-D656-433A-A795-6476703C9160Q37588620-F492F07B-DA42-49D4-A075-294B686AC57AQ38718942-8B2EE27B-AFAD-43D2-B2BE-1FFBE8379E24Q41832140-A3A7176C-D0A1-4EDF-A15E-5DD60C67D69FQ47310629-A2908485-0088-421A-810A-CDF1E6C1DF83Q47696958-F784AB95-4635-4529-887E-AD4F2492D04EQ49940352-56D99B0B-F8CF-4800-8301-C888B67AADDEQ52677958-6DBE6FBB-562A-426B-8FE2-EB42C4095842Q57115565-5F871C5B-0287-4050-A3AA-422EFAF593D4
P2860
EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EPI-001, A Compound Active aga ...... it 5 of the Androgen Receptor.
@en
type
label
EPI-001, A Compound Active aga ...... it 5 of the Androgen Receptor.
@en
prefLabel
EPI-001, A Compound Active aga ...... it 5 of the Androgen Receptor.
@en
P2093
P2860
P50
P1433
P1476
EPI-001, A Compound Active aga ...... it 5 of the Androgen Receptor.
@en
P2093
Alex de la Fuente
Carlos W Bertoncini
Christopher T W Phang
Elzbieta Szulc
Eva De Mol
Iain J McEwan
Victor Buzón
P2860
P304
P356
10.1021/ACSCHEMBIO.6B00182
P577
2016-06-29T00:00:00Z